This commentary reflects on the evolution of clinical judgment in oncology, arguing that mature practice requires not only knowing how to treat aggressively, but also when to refrain. It uses head and neck oncology - particularly HPV-positive oropharyngeal cancer - as a paradigm in which long-term toxicities such as dysphagia, xerostomia, fibrosis, pain, and dependence on nutritional support can transform cure into a life constrained by potentially avoidable morbidity. Highlighting de-escalation strategies tailored to biologic risk, and the growing emphasis on quality of life alongside survival, it calls for a shift from reflexive maximalism toward patient-centered restraint, where functional preservation and dignified survivorship are valued as highly as oncologic control.
Riaz et al. (Thu,) studied this question.